Triazolopyrimidine Derivatives: An Updated Review on Recent Advances in Synthesis, Biological Activities and Drug Delivery Aspects
| dc.contributor.author | Abdelkhalek, Ahmed S. | |
| dc.contributor.author | Attia, Mohamed S. | |
| dc.contributor.author | Kamal, Mohammad A. | |
| dc.date.accessioned | 2025-12-07T08:24:21Z | |
| dc.date.available | 2025-12-07T08:24:21Z | |
| dc.date.issued | 2024-05-26 | |
| dc.description | Review | |
| dc.description.abstract | Molecules containing triazolopyrimidine core showed diverse biological activities, including anti-Alzheimer's, anti-diabetes, anti-cancer, anti-microbial, anti-tuberculosis, anti-viral, anti-malarial, anti-inflammatory, anti-parkinsonism, and anti-glaucoma activities. Triazolopyrimidines have 8 isomeric structures, including the most stable 1,2,4-triazolo[1,5- a] pyrimidine ones. Triazolopyrimidines were obtained by using various chemical reactions, including a) 1,2,4-triazole nucleus annulation to pyrimidine, b) pyrimidines annulation to 1,2,4-triazole structure, c) 1,2,4-triazolo[l,5-a] pyrimidines rearrangement, and d) pyrimidotetrazine rearrangement. This review discusses synthetic methods, recent pharmacological actions and drug delivery perspectives of triazolopyrimidines. | |
| dc.identifier.other | http://dspace.daffodilvarsity.edu.bd:8080/handle/123456789/15997 | |
| dc.identifier.uri | http://dspace.daffodilvarsity.edu.bd:8080/handle/123456789/15997 | |
| dc.language.iso | en_US | |
| dc.publisher | Scopus | |
| dc.source | DIU Institutional Repository | |
| dc.subject | tetrazines | |
| dc.subject | Alzheimer's triazolopyrimidine | |
| dc.subject | pharmacological actions | |
| dc.subject | biology | |
| dc.subject | drug delivery | |
| dc.title | Triazolopyrimidine Derivatives: An Updated Review on Recent Advances in Synthesis, Biological Activities and Drug Delivery Aspects | |
| dc.type | Other |
Files
Original bundle
1 - 1 of 1
